Skip to main content
logo
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
65.29
-0.32 (-0.49%)
At close: Aug 27, 2026, 4:00 PM EDT
64.00
-1.29 (-1.98%)
After-hours: Aug 27, 2026, 5:28 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VOXZOGO Revenue
964.19M926.92M735.09M
VIMIZIM Revenue
792.86M792.05M739.78M
NAGLAZYME Revenue
507.57M485.40M479.58M
PALYNZIQ Revenue
458.83M433.31M355.05M
BRINEURA Revenue
195.82M186.40M169.08M
ALDURAZYME Revenue
183.38M208.51M183.89M
KUVAN Revenue
95.68M99.53M120.90M
ROCTAVIAN Revenue
30.28M35.64M26.07M
Total Net Product Revenue
3.36B3.17B2.81B
Royalty and Other Revenue
42.01M53.49M44.47M
Revenue (Other)
-30.28M-35.64M-26.07M
Revenue (Total)
3.41B3.22B2.85B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Royalty and Other Revenue
42.01M53.49M44.47M
United States Revenue
1.20B1.10B924.81M
Europe Revenue
917.95M874.33M829.03M
Latin America Revenue
461.16M435.48M378.08M
Rest of World Revenue
597.38M544.47M493.63M
Revenue (Other)
183.38M208.51M183.89M
Revenue (Total)
3.41B3.22B2.85B